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Abbreviations 
 
Fmoc, Na-(9-fluorenyl)methyloxycarbonyl; 
HPLC, high pressure liquid chromatography; 
IKCa, intermediate-conductance Ca2+-activated K+ channel; 
Kv, voltage-gated K+ channels; 
MTX, synthetic maurotoxin, a scorpion toxin from Scorpio maurus palmatus venom; 
MALDI-TOF, matrix-assisted laser desorption ionization-time of flight; 
MS, mass spectrometry; 
SKCa, small-conductance Ca2+-activated K+ channel. 
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Abstract: 
Maurotoxin (MTX) is a 34-mer scorpion toxin cross-linked by four disulphide bridges 
that acts on various K+ channel types.  It folds according to an a/b  scaffold, i.e. a 
helix connected to a two stranded b-sheet by two disulphide bridges. In a former 
study, various parameters that affect the oxidation and folding of the reduced form of 
synthetic MTX were investigated in vitro.  It was found that MTX achieves its final 3-
D structure by evolving over time through a series of oxidation intermediates, from 
the least to the most oxidised species. MTX oxidative intermediates can be studied by 
iodoacetamide alkylation of free cysteine residues followed by mass spectrometry 
analysis. Here, we have analysed the effect of Cu2+ on the kinetics of MTX oxidative 
folding and found that it dramatically speeds up the formation of the four-disulphide 
bridged, native- like, MTX (maximal production within 30 minutes instead of > 60 
hours). Cu2+ was also found to prevent the slow transition of a three disulphide-
bridged MTX intermediate towards the final four disulphide-bridged product (12% of 
total MTX). The data are discussed in light of the potential effects of Cu2+ on MTX 
secondary structure formation, disulphide bridging and peptidyl prolyl cis-trans 
isomerisation.  
 
Keywords: scorpion toxin, maurotoxin, oxidative folding, mass spectrometry, 
disulphide bridging, Cu2+. 
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Introduction 
Maurotoxin (MTX) is a scorpion toxin isolated from the Tunisian chactidae Scorpio 
maurus palmatus [1-3]. This basic 34-residue peptide (amino acid sequence: 
VSC1TGSKDC2YAPC3RKQTGC4PNAKC5INKSC6KC7YGC8-NH2) is cross-linked 
according to a C1-C5, C2-C6, C3-C4 and C7-C8 pattern of disulfide bridging [1] and 
adopts the classical a/b  scaffold of most scorpion toxins [4]. The 3-D solution 
structure of MTX has been solved [2]; it is composed of a bent a-helix (residues 6 to 
17) connected by a loop to a two-stranded antiparallel b-sheet (residues 22 to 25 and 
28 to 31). This toxin exhibits a wide range of pharmacological activity since it 
potently blocks voltage-gated Kv channels (Shaker B and Kv1.2), small- (SKCa) and 
intermediate-conductance (IKCa) Ca2+-activated K+ channels [1,3,5,6]. Previous 
studies have evidenced the relationship that exists between disulphide bridging, 3D-
structure and spatial distribution of toxin amino acid residues key to pharmacology 
[6-8]. To gain its full pharmacological activity, the reduced form of chemically 
produced MTX needs to undergo a full process of folding and oxidation in vitro 
[9,10]. Small but highly reticulated peptides, such as MTX, possess ideal 
characteristics to investigate peptide folding and oxidation. First, large quantities of 
MTX can be obtained by chemical synthesis. Second, chemically produced MTX can 
be directly recovered in its reduced and unfolded state after final acidolytic treatment. 
It requires an appropriate folding/oxidation buffer to reach its biologically active 3-D 
structure. In a classical oxidative buffer (e.g. air-exposed 0.2 M Tris/HCl buffer, pH 
8.3), oxidation of MTX in vitro has a slow time scale, which allows for a detailed 
kinetic analysis of its incremental reticulation [9,10]. In previous studies, we were 
able to monitor the sequential formation of each MTX oxidation intermediates, from 
the less (1 disulphide-bridged MTX species) to the most oxidised form (native- like, 4 
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disulfide-bridged MTX) [9,10]. This was achieved by iodoacetamide alkylation of 
free cysteine residues (not engaged in disulphide bridges) of the reduced form and 
oxidation intermediates of MTX. This treatment allowed one to discriminate between 
the various MTX oxidation intermediates using mass spectrometry (MS) analysis. 
Various parameters were evaluated such as temperature, pH, ionic strength, 
redox potential, presence or not of some enzymes (protein disulphide isomerase (PDI) 
or peptidylprolyl cis-trans isomerase (PPIase)), that all affected to some extent MTX 
folding and oxidation. The best experimental conditions allowed for the formation of 
100% of four-disulphide-bridged MTX in ca. 10 h and relied on the combined use of 
PDI and PPIase [9]. Addition of PPIase to the oxidation buffer was found to be 
particularly relevant to favour isomerisation between the cis and trans configurations 
of prolyl imidic peptide bonds; a rate limiting step in protein folding [11,12]. In 
approximately 85% of the cases, the two prolyl imidic peptide bonds of MTX (CO-N 
bonds between residues 11-12 and 19-20) are in a favourable configuration 
(presumably trans) for the formation of the four disulphide-bridged MTX, whereas 
the remaining 15% allows for the formation of (a) three disulphide-bridged 
intermediate(s) only. The conversion between the three-disulphide-bridged 
intermediate(s) towards the four disulphide-bridged end product is rate- limiting and 
shown to be PPIase-sensitive [9]. Whether this last step implies reshuffling of 
disulphide connections among the three-disulphide-bridged intermediate(s) remains 
an open question. 
From previous data, one may suggest the existence of a complex interplay 
between folding and oxidation of MTX, which was evidenced during the progressive 
acquisition of its stabilised secondary structures and disulphide bridges. In particular, 
the helical structure appears at the same time than the one disulphide-bridged species 
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of MTX, whereas the b-sheet structure appears later on when the two- or three-
disulphide-bridged MTX intermediates are detected [10]. With the aim of accelerating 
the process of MTX oxidative folding, we searched for an agent that has the capability 
to speed up peptide folding and oxidation, such as a redox-active metal. Because 
copper ions easily cycle between Cu2+ and Cu+, copper complexes could participate in 
non-enzymatic redox processes. Indeed, copper behaves as a potent oxidant of thiol 
groups [13] and is beneficial for both protein folding [14-19] and oxidation [13,20]. 
We therefore investigated the potential effects of copper ions on the oxidative folding 
of reduced MTX in vitro. Since both processes of folding and oxidation of MTX are 
linked, addition of copper ions in the oxidation milieu is expected to increase the rate 
of formation of highly reticulated MTX species. 
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Materials and Methods 
 
Materials. N-a-Fmoc-L-amino acid derivatives, Fmoc-amide resin, and reagent s used 
for peptide synthesis were purchased from Perkin-Elmer (Shelton, CT, U.S.A.) and 
Neosystem Laboratoire (Strasbourg, France). Solvents were analytical grade products 
from SDS (Peypin, France). Iodoacetamide and copper ions were obtained from 
Sigma (St. Louis, MO, U.S.A.). 
 
Chemical synthesis and characterisation of MTX. The peptide was obtained by the 
solid-phase method using a peptide synthesiser (Model 433A, Applied Biosystems 
Inc.) as previously described [1]. Briefly, the peptide chain was assembled stepwise 
on 0.25 mmol of Fmoc-amide resin (0.65 mmol of amino group/g) using 1 mmol of 
Fmoc-amino acid derivatives activated as their hydroxybenzotriazole active esters. 
The reduced MTX was purified to > 99% homogeneity by reversed-phase high-
pressure liquid chromatography (HPLC) (Perkin-Elmer Life Sciences, C18 Aquapore 
ODS 20 mm, 250 mm x 10 mm) by means of a 70-min linear gradient of 0.08% (v/v) 
trifluoroacetic acid (TFA)/ 0-35% acetonitrile in 0.1% (v/v) TFA/H2O at a flow rate 
of 2 ml/min (l  = 230 nm). The homogeneity and identity of reduced MTX was 
assessed by: (i) analytical C18 reversed-phase HPLC, (ii) amino acid analysis, (iii) 
Edman sequencing and (iv) MS analysis. After lyophilisation of the purified reduced 
MTX, its fully reduced state was verified by iodoacetamide-based alkylation of the 
eight free cysteine residues, analytical C18 reversed-phase HPLC, and MS analysis. 
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MS analyses of samples after alkylation of the free thiol groups of MTX during 
its process of oxidative folding. The lyophilized reduced MTX was dissolved in 100 
ml of oxidation buffer (200 mM Tris/HCl buffer, pH 8.3 with or without 10 mM 
CuCl2) at 0.4 mM peptide concentration and exposed to air to allow oxidation. 
Samples of 5 ml were alkylated by using 5 ml of a 85 mM iodoacetamide solution for 
30 s at 25°C. The MS analyses were carried out in the linear mode using a MALDI-
TOF-MS (Voyager DE-RP, Perseptive Biosystems Inc., Framingham, MA, U.S.A.). 
The parameters fixed before MS analyses were: 20 kV as accelerating voltage, 92% 
and 0.1% as grid and guide wire voltages, respectively, 100 ns as delayed extraction 
time, and 256 average scans. The data were analysed by using the GRAMS/386 
software. The matrix used to prepare the samples was a-cyano-4-hydroxycinnamic 
acid (10 mg/ml) in TFA/acetonitrile/water (0.4:49.8:49.8, by vol.). The peptide 
samples (1 ml) were placed on a 100-well plate, and 1 ml of matrix solution was 
added. This mixture was dried prior to MS analysis. For each condition assay, 
samples were collected at different times (0-80 h), and the peptide species were 
analysed by their respective masses after calibration with appropriate peptide 
standards. The peptides in the sample were then accurately quantified by the total 
counts of ionized molecules detected (areas of peaks). The accuracy of the relative 
proportions between oxidized and reduced MTX species was demonstrated using 
control samples in which mixtures of known quantities of purified peptides were 
preformed (see [9]). 
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Results and Discussion 
Analysis by MALDI-TOF MS of the oxidation process of reduced MTX in vitro 
The reduced MTX was obtained by solid-phase peptide synthesis using 
Fmoc/t-butyl chemistry [9,21]. After cleavage from the solid support, the reduced 
MTX was purified to homogeneity (> 99%) by means of C18 phase-reversed HPLC 
in acidic conditions (pH 2.5) to prevent oxidation. The reduced state of MTX was 
further verified by MALDI-TOF MS immediately after solubilisation in oxidation 
buffer (0.2 M Tris/HCl, pH 8.3) and alkylation of free cysteine residues, as described 
in Materials and Methods.  
The Tris/HCl oxidation buffer (0.2 M Tris/ HCl, pH 8.3) is commonly used 
for an oxidative folding of reticulated peptides. This buffer condition was therefore 
used to investigate the oxidation process of reduced MTX. Studying the oxidation 
process of reduced MTX by MALDI-TOF MS poses two problems that need to be 
overcome. First, because MTX species differ at most by 8 Da (reduced versus fully 
oxidised MTX), the MS technique is not discriminative enough to allow an adequate 
separation and accurate quantification of each of its species. The use of iodoacetamide 
alkylation, which adds 57 Da to each free thiol group, permits a much better peak 
separation and quantification. In this case, each MTX species is separated from the 
closest one by 114 Da, instead of 2 Da in the absence of alkylation. Second, although 
the MALDI-TOF MS is not always considered as a quantitative technique, we 
previously demonstrated that it could be used to quantify properly the various MTX 
species [9,10]. The kinetics of disappearance of reduced MTX and appearance of the 
oxidized MTX intermediates, including the fully oxidized form, were followed over 
time by MS analysis after alkylation of the remaining free thiol groups. As shown in 
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Figure 1, reduced MTX disappears within 10 h of folding/oxidation to convert to 
oxidised species. The one-, two-, three- and four-disulphide bridged MTX species 
appear sequentially over time from the least (intermediates with one disulphide 
bridge) to the most oxidised species (native-like, four-disulphide-bridged MTX). 
Maximal productions of these MTX intermediates are 2.5 h (one-disulphide-bridged), 
4.5 h (two-disulphide-bridged), 11 h (three-disulphide-bridged) and 65 h (four-
disulphide-bridged). Of note, plateaux of disappearances (two- and three-disulphide-
bridged MTX) and appearance (four-disulphide-bridged MTX) of oxidation 
intermediates are observed. As previously demonstrated, these plateaux correspond to 
the rate- limiting isomerisation from cis to trans of peptidylprolyl bonds [9]. 
Noteworthy, all reduced molecules are converted to the fully oxidised, native-like, 
bioactive form of MTX at the end of the oxidation process. 
 
Effect of copper ions on the kinetics of oxidation of reduced MTX in vitro 
Copper ions (Cu2+) have been described to markedly speed up the oxidative 
folding of peptides [13-20]. When they are added (at 10 mM concentration) to the 
oxidation buffer, the kinetics of oxidative folding is dramatically increased (Figure 2). 
The process is so fast that we were unable to monitor the disappearance of reduced 
MTX, as well as the appearance and disappearance of the one- and two-disulphide-
bridged MTX species. This suggests that these oxidation intermediates have very 
short half- lives. Indeed, the reduced MTX apparently evolves directly towards either 
three-disulphide-bridged intermediate(s) (12%) or the four-disulphide-bridged, native-
like, MTX (88%). A maximal production of these two species is obtained in ca. 30 
min in vitro, indicating that the addition of copper ions increases the kinetics of 
oxidation by a factor of 22- (three-disulphide-bridged MTX) to 130-fold (fully 
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oxidised MTX). These plateaux of three- and four-disulphide-bridged MTX species 
remain stable up to 80 h. Therefore, no interconversion between both species could be 
detected. Interestingly, the plateau level (12%) of the three-disulphide-bridged MTX 
in the presence of copper ions is identical to the long- lasting plateau level observed in 
the absence of copper ions (Figure 1). This is coherent with the cis configuration of 
Xaa-Pro bonds, which represents ca. 10% of the total Xaa-Pro bonds in proteins [22]. 
Although copper ions dramatically increase the kinetics of MTX oxidative folding, 
one drawback of its use appears to be the apparent lack of full interconversion of 12% 
of the three-disulfide-bridged species towards the final MTX product. 
Characterisation of the four-disulphide-bridged MTX reveals that it is 
indistinguishable from its native counterpart both in the absence or presence of copper 
ions (data not shown). 
 
Concluding remarks 
Oxidation of reduced MTX is intimately linked to its folding. In other terms, 
the correct connection pattern between half-cystine residues requires also the proper 
folding of MTX, in this case the acquisition of its helical and b-sheet structures that 
form an a/b-scaffold. It would be expected that if folding occurs rapidly with the 
adequate positioning of toxin secondary structures, then the oxidation process would 
also proceed rapidly, allowing the final native fold to be stabilised early. However, 
the folding/oxidation pathway is probably more complex and it is likely that the 
peptide undergoes a series of “trial/error” steps by following a downhill favourable 
energetic slope (the low-energy conformation being favoured). Also, some of the 
folding steps are slow ones, such as the peptidylprolyl cis-trans isomerisation. It is 
therefore conceivable that the formation of all four native-like disulphide bridges of 
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MTX requires the occurrence of cis to trans isomerisation. Non-native-like disulphide 
bridges likely undergo a process of reshuffling that would progressively yield native-
like disulphide bridging and maintain the most favourable energetic state of MTX 
conformation. It has been shown that molecules are greatly aided by chaperone 
proteins in their search for a bioactive conformation. In the case of MTX, catalytic 
activities of PDI and PPIase have been evidenced [9]. Previous reports hint that 
copper ions may play a similar role by favouring the acquisition of secondary 
structures and by catalysing disulphide bridging [12-20]. Our data show that copper 
ions do indeed catalyse formation of MTX disulphide bridges. By favouring 
disulphide bridge formation, copper ions also seem to lock MTX in two stable 
oxidation states, i.e. three- and four-disulphide-bridged species. The use of copper 
ions prevents the slow interconversion between some of the three-disulphide bridged 
MTX species (12% of the total species that are likely to possess one or two cis 
configurations of Xaa-Pro bonds) towards the four-disulphide-bridged MTX. The end 
products obtained with copper ions in oxidation buffer appear to represent “naturally” 
occurring conformational states of MTX, as the same are present in the absence of 
copper ions, albeit produced with slower kinetics. From the data, we speculate that 
once MTX disulphide bridges are formed in the presence of copper ions, reshuffling is 
prevented. This could possibly block the final conversion of the remaining 12% three-
disulphide-bridged molecules towards fully oxidised MTX, if reshuffling is 
concerned. Alternatively, copper ions may prevent the cis to trans isomerisation of 
peptidylprolyl bonds by stabilising some structural elements, and possibly secondary 
structures. This effect would  not be detected for one- and two-disulphide-bridged 
species since, at this stage, MTX is in the process of acquiring its stabilised secondary 
structures [10]. Finally, it was shown that metal ions like copper could act on the cis 
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to trans isomerisation equilibrium of proline residues in peptides [23]. Copper has 
been reported to bind on the ionised amide nitrogen, which inhibits the trans 
configuration of the Xaa-Pro bond. It is therefore possible that copper ions stabilise 
the cis configuration of the Xaa-Pro bond. The results obtained with copper ions on 
the oxidative folding of reduced MTX in vitro suggest that this method could be 
beneficial to peptide folding/oxidation, and of general interest to the peptide chemist 
dealing with the chemical production of reticulated peptides. 
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Figure legends  
 
Figure 1 Evolution of MTX oxidation in relative percentages of the various MTX 
species as a function of time of oxidative folding, as assessed by MALDI-TOF MS. 
MTX species from the samples were Cys-alkylated by iodoacetamide prior to MS 
analyses. The oxidation process was started at 25°C with 0.4 mM reduced MTX in 
oxidation buffer without copper ions. Symbols: filled squares (reduced MTX, thus 
without any disulphide bridge (0 S-S)); open triangles (one-disulphide-bridged MTX 
species (1 S-S)); filled inverted triangles (two-disulphide-bridged MTX species (2 S-S)); 
open diamonds (three-disulphide-bridged MTX species (3 S-S)); and filled circles (native 
like, four-disulphide-bridged MTX (4 S-S)). 
 
Figure 2 Effect of copper ions (Cu2+) on the evolution of MTX oxidation over time. 
Same experimental conditions as in Figure 1, except that 10 mM CuCl2 was added to the 
oxidation buffer. 
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